Industry Experts blogging about Dry Eye Disease
Dry Eye Disease is the most common pathology you will see in your clinic each day. Dr. Kelly Nichols addressed the need for clinicians to answer the call. From Contact Lenses Today: http://www.cltoday.com/new/issue_012212.asp Unmet Need in Dry Eye A recent "Industry News" article in the AOA News caught my … [Read more...]
In January's edition of Cataract and Refractive Surgery Today, Jay Pepose, MD, PhD says.... A lot depends on treating patients with dry eye disease. Nearly one in five individuals in North America has dry eye disease (DED); it may be one of the most common yet frequently undiagnosed and untreated problems seen every day by … [Read more...]
SAN DIEGO, January 24, 2012 -- TearLab Corporation (NASDAQ:TEAR; TSX:TLB) ("TearLab" or the "Company") announced today that, after reviewing and accepting labeling submitted to it by the Company, the U.S Food and Drug Administration (“FDA”) has now granted Waiver categorization under the Clinical Laboratory Improvement … [Read more...]
Normal subjects showed no variation over a day, confirming that a properly functioning tear film is characterized by its low and stable concentration. This study provides further evidence that eye-to-eye variability is the hallmark of Dry Eye Disease. As shown in Lemp et al. [AJO 2011], dry eye disease subjects showed … [Read more...]
See this weeks Practice Pearl from Paul Karpecki, OD where he discusses the many diagnostic instruments he would like to include in his "dream dry eye practice". He mentions the TearLab Osmolarity System, among others. http://www.revoptom.com/email/010912_pearl86_v2.html … [Read more...]
Biomarkers are becoming more and more important in patient care and this article by Elyse Chaglasian, OD presents multiple examples how eye care practitioners can care for their patients..... http://www.reviewofcontactlenses.com/content/c/31008/ … [Read more...]
The advent of tear osmolarity as a practical tool for diagnosis, determination of severity of disease and as a reliable objective measure of response to treatment is a game changer for clinicians faced daily in their offices with patients suffering from this disease. TearLab Corporation recently received a letter from the FDA … [Read more...]
December has turned out to be quite a month for TearLab Corporation. TearLab achieved their largest milestone last week when they received FDA communication granting them the CLIA waiver for the TearLab® Osmolarity System (pending labeling agreements). In addition, in a press release on Tuesday of this week, TearLab announced … [Read more...]
The American Academy of Ophthalmology in September published a partial revision of the Preferred Practice Patterns for Dry Eye. In this, tear osmolarity was added to the recommended diagnostic tests for dry eye disease and specifically the TearLab was referenced. This recognition by the Academy’s panel of the critical role tear … [Read more...]
Dr. McDonald is the Cornea/refractive/anterior segment specialist, Ophthalmic Consultants of Long Island, Lynbrook, NY. She is presently an Adjunct Clinical Professor of Ophthalmology at Tulane University School of Medicine in New Orleans and a Clinical Professor of Ophthalmology at New York University (NYU) in Manhattan. Dr … [Read more...]
